Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Other solid neoplasm × 30 days × Clear all

Phase

Phase 1 78 Phase 1/2 42 Phase 2 28 Phase NA 17 Phase EARLY_PHASE1 3 Phase 3 3 Phase 4 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 12 Gastrointestinal 12 Head & Neck 9 Genitourinary 9 Gynecologic 6 Breast 6 Sarcoma 5 Lymphoid 5 Plasma cell 4 Other hematologic neoplasm 4 Myeloid 4 Tumor-Agnostic 3 Endocrine 3 CNS 2 Other solid neoplasm 1 Other 1 NET 1 Dermatologic 1 Classical hematology 1

Conditions

Resectable MMR-deficient Solid Tumors 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06279130 2026-03-05

NEOASIS

The Netherlands Cancer Institute

Phase 2/3 Recruiting

Other solid neoplasm

Resectable MMR-deficient Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡